Editorial comment: Multiple myeloma and HIV infection - Causal or casual coincidence?

AIDS Reader

Volumn 13, Issue 8, 2003, Pages 386-387

  Pantanowitz, Liron ^a   Dezube, Bruce J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DEXAMETHASONE; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; THALIDOMIDE;

CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE MYELOMA; NOTE; VIRUS LOAD;

ANTI-HIV AGENTS; CAUSALITY; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTERLEUKIN-6; MULTIPLE MYELOMA; RISK FACTORS; THALIDOMIDE;

EID: 0042974965     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. von Keyserlingk H, Baur R, Stein H, et al. Multiple myeloma in a patient at risk for AIDS. Cancer Detect Prev. 1990;14:403-404.
2. Shokunbi WA, Okpala IE, Shokunbi MT, et al. Multiple myeloma co-existing with HIV-1 infection in a 65-year-old Nigerian man. AIDS. 1991;5:115-116.
3. Kumar S, Kumar D, Schnadig VJ, et al. Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol. 1994;102:633-639.
4. Nosari AM, Landonio G, Cantoni S, et al. Multiple myeloma associated to HIV infection: report of two patients. Eur J Haematol. 1996;56:98-99.
5. Talib SH, Singh J, Ranga S, Talib VH. Multiple myeloma complicating HIV-infection. A case report. Indian J Pathol Microbiol. 1997;40:413-416.
6. Faure I, Viallard JF, Mercie P, et al. Multiple myeloma in two HIV-infected patients. AIDS. 1999;13:1797-1799.
7. Pouli A, Lemessiou H, Rontogianni D, et al. Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Ann Hematol. 2001;80:557-560.
8. Mbanya DN, Minkoulou EM, Kaptue LN. HIV-1 infection in adults with haematological malignancies in Yaounde, Cameroon. West Afr J Med. 2002;21:183-184.
9. Aboulafia DM. Thalidomide-based treatment for HIV-associated multiple myeloma: a case report. AIDS Reader 2003;13:383-389.
10. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
11. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol. 2000;27:390-401.
12. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS. 1999;13:839-843.
13. Sitas F, Pacella-Norman R, Carrara H, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer. 2000;88:489-492.
14. Frisch M, Biggar RJ, Engels EA, Goedert JJ, AIDS-Cancer Match Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
15. Yee TT, Murphy K, Johnson M, et al. Multiple myeloma and human immunodeficiency virus-1 (HEV-1) infection. Am J Hematol. 2001;66:123-125.
16. Fiorino AS, Atac B. Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia. 1997;11:2150-2156.
17. Stewart JM, Krishnamurthy S. Fine-needle aspiration cytology of a case of HIV-associated anaplastic myeloma. Diagn Cytopathol. 2002;27:218-222.
18. Lallemand F, Fritsch L, Cywiner-Golenzer C, Rozenbaum W. Multiple myeloma in an HIV-positve man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol. 1998;39:506-508.
19. Miranda EG, Iravani S, Doll DC. Unusual presentations of malignancy. Case 2. Breast plasmacytoma in a patient with human immunodeficiency virus. J Clin Oncol. 2001;19:3290-3291.
20. Konrad RJ, Kricka LJ, Goodman DB, et al. Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositve patient. N Engl J Med. 1993;328:1817-1819.
21. Jin DK, Nowakowski M, Kramer M, Essex DW. Hyperviscosity syndrome secondary to a myeloma-associated IgG(1)kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen. Am J Hematol. 2000;64:210-213.
22. Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am. 1991;5:195-214.
23. Ng VL, Chen KH, Hwang KM, et al. The clinical significance of human immunodeficiency virus type 1-associated paraproteins. Blood. 1989;74:2471-2475.
24. Lefrere JJ, Debbia M, Lambin P. Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol. 1993;84:151-155.
25. Lu CM, Dezube BJ, Pantanowitz L. Human immunodeficiency virus infection masquerading as monoclonal gammopathy of undetermined significance. New Engl J Med. In press.
26. Cauda R, Lucia MB, Marasca G, et al. Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol. 1999;63:134-135.
27. Jacobson MA, Khayam-Bashi H, Martin JN, et al. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr. 2002;31:472-477.
28. Kentos A, Vekemans M, Van Vooren JP, et al. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Bone Marrow Transplant. 2002;29:273-275.